Patent details
301081
Product Name:
Avelumab
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301081
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2785375
Status:
SPC granted but not yet in force
Application number:
301081
Procedural language:
Dutch
First Applicant Residence Country:
Germany (DE)
Marketing Authorization
Marketing Authorization Number:
EU/1/17/1214
Marketing Authorization Type:
EEA
Marketing Authorization Date:
20/09/2017
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
18/12/2020
First Marketing Authorization date:
20/09/2017
Grant date:
04/02/2021
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
21/12/2020
SPC/SPC Extension Expiration Date:
19/09/2032
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
18/12/2020
Name:
Merck Patent GmbH
Address:
Frankfurter Strasse 250, 64293 DARMSTADT, Germany (DE)
Agent
Name:
drs. W.H.P. Derks
From:
18/12/2020
Address:
HOYNG ROKH MONEGIER B.V.
Rembrandt Toren 30e verdieping
Amstelplein 1, 1096 HA, Amsterdam, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
SPC
Journal edition number:
06/21
Publication date:
10/02/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
Bulletin Heading:
SPC
Journal edition number:
52/20
Publication date:
23/12/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
04/02/2021
Outgoing Correspondence
Decision grant
1
PDF
/4/0/3/5/3/0800635304/docs/301081_4_393194l504a.pdf
04/02/2021
Certificate
Certificate
1
PDF
/4/0/3/5/3/0800635304/docs/301081_13_spcmedcertificate20210204100753565.pdf
03/02/2021
SPC Documents
Summary of the characteristics of the product
30
PDF
/4/0/3/5/3/0800635304/docs/301081_0_supplprotectioncertificate20210203015322824.pdf
03/02/2021
SPC Documents
Annex SPC
14
PDF
/4/0/3/5/3/0800635304/docs/301081_1_supplprotectioncertificate20210203015322984.pdf
03/02/2021
SPC Documents
Annex SPC
4
PDF
/4/0/3/5/3/0800635304/docs/301081_8_supplprotectioncertificate20210203015322918.pdf
03/02/2021
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/4/0/3/5/3/0800635304/docs/301081_9_incomingcorrespondencepaper20210203014736796.pdf
24/12/2020
Outgoing Correspondence
Letter to applicant
1
PDF
/4/0/3/5/3/0800635304/docs/301081_3_386301l173.pdf
21/12/2020
Outgoing Correspondence
Confirmation receipt request
1
PDF
/4/0/3/5/3/0800635304/docs/301081_2_385384l174.pdf
18/12/2020
SPC Documents
Annex SPC
4
PDF
/4/0/3/5/3/0800635304/docs/301081_5_supplprotectioncertificate20201221085824224.pdf
18/12/2020
Application Form
First filed application form
3
PDF
/4/0/3/5/3/0800635304/docs/301081_6_applicationform20201221084216209.pdf
18/12/2020
SPC Documents
Accompanying letter SPC
1
PDF
/4/0/3/5/3/0800635304/docs/301081_7_supplprotectioncertificate20201221085420170.pdf
18/12/2020
SPC Documents
Marketing Authorization SPC
4
PDF
/4/0/3/5/3/0800635304/docs/301081_10_supplprotectioncertificate20201221085741298.pdf
18/12/2020
SPC Documents
Annex SPC
3
PDF
/4/0/3/5/3/0800635304/docs/301081_11_supplprotectioncertificate20201221085920166.pdf
18/12/2020
SPC Documents
Annex SPC
10
PDF
/4/0/3/5/3/0800635304/docs/301081_12_supplprotectioncertificate20201221085638843.pdf